Cargando…

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents

Eradicating HIV-1 infection is difficult because of the reservoir of latently infected cells that gets established soon after infection, remains hidden from antiretroviral drugs and host immune responses, and retains the capacity to reignite infection following the cessation of treatment. Drugs call...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Vipul, Dixit, Narendra M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833289/ https://www.ncbi.nlm.nih.gov/pubmed/29451894 http://dx.doi.org/10.1371/journal.pcbi.1006004

Ejemplares similares

Synergies and trade-offs between sanitation and the sustainable development goals
por: Parikh, Priti, et al.
Publicado: (2021)

Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression
por: Curty, Gislaine, et al.
Publicado: (2022)

Global synergies and trade-offs between multiple dimensions of biodiversity and ecosystem services
por: Girardello, Marco, et al.
Publicado: (2019)

NSC95397 is a Novel HIV Latency Reversing Agent
por: Nichols Doyle, Randilea, et al.
Publicado: (2023)

Straggler-Aware Distributed Learning: Communication–Computation Latency Trade-Off
por: Ozfatura, Emre, et al.
Publicado: (2020)

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2019)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Ecosystem-based adaptation in Lake Victoria Basin; synergies and trade-offs
por: Agol, Dorice, et al.
Publicado: (2021)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
por: Debrabander, Quinten, et al.
Publicado: (2023)

Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
por: Hattori, Shin-ichiro, et al.
Publicado: (2018)

The nonequilibrium mechanism of noise-enhanced drug synergy in HIV latency reactivation
por: Guo, Xiaolu, et al.
Publicado: (2022)

Analyzing SDG interlinkages: identifying trade-offs and synergies for a responsible innovation
por: Luttikhuis, Nikki, et al.
Publicado: (2023)

Ecosystem Services at the Farm Level—Overview, Synergies, Trade‐Offs, and Stakeholder Analysis
por: Morizet‐Davis, Jonathan, et al.
Publicado: (2023)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
por: Taylor, Jared P., et al.
Publicado: (2020)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
por: Li, Rui, et al.
Publicado: (2023)

Latency Reversing Agents: Kick and Kill of HTLV-1?
por: Schnell, Annika P., et al.
Publicado: (2021)

Trade-offs and synergies between yield, labor, profit, and risk in Malawian maize-based cropping systems
por: Komarek, Adam M., et al.
Publicado: (2018)

Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
por: Covino, Daniela Angela, et al.
Publicado: (2022)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents
por: Vollbrecht, Thomas, et al.
Publicado: (2020)

Trade-Off and Synergy among Ecosystem Services in the Guanzhong-Tianshui Economic Region of China
por: Qin, Keyu, et al.
Publicado: (2015)

Groundwater and human development: synergies and trade-offs within the context of the sustainable development goals
por: Velis, Maya, et al.
Publicado: (2017)

Editorial: Diets, Public Health and Environmental Degradation: Trade-Offs, Synergies, and Policy Interventions
por: Wu, Tong, et al.
Publicado: (2022)

Economic-ecological services and their trade-offs or synergies of agricultural landscapes in Xiangxi, central China
por: Xiang, Hui
Publicado: (2023)

The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
por: Ait-Ammar, Amina, et al.
Publicado: (2020)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen
por: Liu, Hongbing, et al.
Publicado: (2021)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
por: Salahong, Thanarat, et al.
Publicado: (2021)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells
por: Boucau, Julie, et al.
Publicado: (2020)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
por: Li, Shifei, et al.
Publicado: (2023)

System-level consequences of synergies and trade-offs between SDGs: quantitative analysis of interlinkage networks at country level
por: Dawes, Jonathan H. P., et al.
Publicado: (2022)

Impact of latency‐reversing agents on human macrophage physiology
por: Hany, Laurent, et al.
Publicado: (2022)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
por: Covino, Daniela A., et al.
Publicado: (2021)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
por: Søgaard, Ole S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nbmma47vqsfqgavn557p2qtiq3